These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11092546)

  • 41. REDOR with a relative full-echo reference.
    Mehta AK; Cegelski L; O'Connor RD; Schaefer J
    J Magn Reson; 2003 Jul; 163(1):182-7. PubMed ID: 12852922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calculation of concentrations of equilibrium components in an in vitro activity test of vancomycin antibiotics and the possible mode of action.
    Yan H; Cheng X; He B
    Biophys Chem; 1998 Aug; 74(2):107-15. PubMed ID: 9760722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.
    Leung SS; Tirado-Rives J; Jorgensen WL
    Bioorg Med Chem; 2009 Aug; 17(16):5874-86. PubMed ID: 19620008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
    J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An analysis of the origins of a cooperative binding energy of dimerization.
    Williams DH; Maguire AJ; Tsuzuki W; Westwell MS
    Science; 1998 May; 280(5364):711-4. PubMed ID: 9563941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The glycopeptide antibiotic producer Streptomyces toyocaensis NRRL 15009 has both D-alanyl-D-alanine and D-alanyl-D-lactate ligases.
    Marshall CG; Wright GD
    FEMS Microbiol Lett; 1997 Dec; 157(2):295-9. PubMed ID: 9435111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of structural variations in the peptidoglycan of vancomycin-susceptible Enterococcus faecium: understanding glycopeptide-antibiotic binding sites using mass spectrometry.
    Patti GJ; Chen J; Schaefer J; Gross ML
    J Am Soc Mass Spectrom; 2008 Oct; 19(10):1467-75. PubMed ID: 18692403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A strategy for the generation of surfaces presenting ligands for studies of binding based on an active ester as a common reactive intermediate: a surface plasmon resonance study.
    Lahiri J; Isaacs L; Tien J; Whitesides GM
    Anal Chem; 1999 Feb; 71(4):777-90. PubMed ID: 10051846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorescence assay to predict activity of the glycopeptide antibiotics.
    Vimberg V; Gazak R; Szűcs Z; Borbás A; Herczegh P; Cavanagh JP; Zieglerova L; Závora J; Adámková V; Balikova Novotna G
    J Antibiot (Tokyo); 2019 Feb; 72(2):114-117. PubMed ID: 30504918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On-column synthesis coupled to affinity capillary electrophoresis for the determination of binding constants of peptides to glycopeptide antibiotics.
    Azad M; Silverio C; Zhang Y; Villareal V; Gomez FA
    J Chromatogr A; 2004 Feb; 1027(1-2):193-202. PubMed ID: 14971503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zn(II) mediates vancomycin polymerization and potentiates its antibiotic activity against resistant bacteria.
    Zarkan A; Macklyne HR; Chirgadze DY; Bond AD; Hesketh AR; Hong HJ
    Sci Rep; 2017 Jul; 7(1):4893. PubMed ID: 28687742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.
    Groves P; Searle MS; Mackay JP; Williams DH
    Structure; 1994 Aug; 2(8):747-54. PubMed ID: 7994574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis.
    Goldman RC; Gange D
    Curr Med Chem; 2000 Aug; 7(8):801-20. PubMed ID: 10828288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of action of oritavancin and related glycopeptide antibiotics.
    Allen NE; Nicas TI
    FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.
    van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin.
    Rao J; Lahiri J; Isaacs L; Weis RM; Whitesides GM
    Science; 1998 May; 280(5364):708-11. PubMed ID: 9563940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification and inhibition of vancomycin group antibiotics by formaldehyde and acetaldehyde.
    Heck AJ; Bonnici PJ; Breukink E; Morris D; Wills M
    Chemistry; 2001; 7(4):910-6. PubMed ID: 11288883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct fluorescence polarization assay for the detection of glycopeptide antibiotics.
    Yu L; Zhong M; Wei Y
    Anal Chem; 2010 Aug; 82(16):7044-8. PubMed ID: 20704393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using surface plasmon resonance to directly identify molecules in a tripeptide library that bind tightly to a vancomycin chip.
    Tseng MC; Chu YH
    Anal Biochem; 2005 Jan; 336(2):172-7. PubMed ID: 15620881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci.
    Hughes CS; Longo E; Phillips-Jones MK; Hussain R
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1951-1959. PubMed ID: 28511809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.